Heart Test Laboratories has submitted Form 1-A to the SEC for a new securities offering, with a balance sheet showing cash and cash equivalents of $4.05M and total assets of $7.78M. The company's total liabilities stand at $3.76M, with stockholders' equity at $4.02M.The company has 947,821 shares of common stock listed on the Nasdaq Capital Market, along with 17,250 IPO warrants. Additionally, there are 41,805 other warrants and 380,440 shares of convertible preferred stock outstanding. The company maintains its principal executive offices in Southlake, Texas.The filing indicates the company's intention to conduct a securities offering, though specific pricing and total offering amount details remain undetermined. The offering will include equity securities, options, warrants, and rights to acquire additional securities.

Heart Test Laboratories has submitted Form 1-A to the SEC for a new securities offering, with a balance sheet showing cash and cash equivalents of $4.05M and total assets of $7.78M. The company's total liabilities stand at $3.76M, with stockholders' equity at $4.02M.The company has 947,821 shares of common stock listed on the Nasdaq Capital Market, along with 17,250 IPO warrants. Additionally, there are 41,805 other warrants and 380,440 shares of convertible preferred stock outstanding. The company maintains its principal executive offices in Southlake, Texas.The filing indicates the company's intention to conduct a securities offering, though specific pricing and total offering amount details remain undetermined. The offering will include equity securities, options, warrants, and rights to acquire additional securities.